Blood markers may predict lung decline in rare disease

NCT ID NCT04844359

First seen Apr 12, 2026 · Last updated May 14, 2026 · Updated 5 times

Summary

This study enrolls up to 150 people with chronic hypersensitivity pneumonitis, a lung condition caused by inhaling certain substances. Researchers will follow participants for 24 months to see if specific markers in the blood can predict when the disease gets worse. The goal is to better understand the disease and improve future care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERSENSITIVITY PNEUMONITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

  • National Jewish Health

    Denver, Colorado, 80206, United States

  • University of Arizona

    Tucson, Arizona, 85719, United States

  • University of California Davis

    Sacramento, California, 95817, United States

  • University of Chicago

    Chicago, Illinois, 60637, United States

  • University of Texas Southwestern

    Dallas, Texas, 75390, United States

  • University of Utah

    Salt Lake City, Utah, 84108, United States

Conditions

Explore the condition pages connected to this study.